Skip to main content

Want a detailed portfolio tracker?

Mustang Bio (MBIO) P/E (2017 - 2026)

Mustang Bio (MBIO) P/E from Aug 22, 2017 to Jul 21, 2026. The TTM Mustang Bio (MBIO) P/E is -1.34. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Mustang Bio (MBIO)

YearP/EChange
2026-1.34+211.50%
2025-0.43+623.01%
2024-0.06-86.76%
2023-0.45-90.25%
2022-4.63-76.21%
2021-19.44-56.14%
2020-44.33-7.23%
2019-47.79+26.03%
2018-37.92-74.70%
2017-149.89N/A

Comparison Mustang Bio (MBIO) P/E with competitors

Mustang Bio (MBIO) P/E is -1.34.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.13%
NBYStablecoin Development Corp0.00-100.32%
ENLVEnlivex Ltd0.07-105.56%
FGENFibroGen Inc0.24-117.85%
CHRSCoherus Biosciences Inc0.85-163.10%
FBIOFortress Biotech Inc0.95-170.58%
ORMPOramed Pharmaceuticals Inc1.50-211.78%
AGENAgenus Inc3.01-323.81%
INVAInnoviva Inc3.15-334.55%
VXRTVaxart Inc3.55-363.98%
CRMDCorMedix Inc3.63-369.83%
CVACCureVac N.V.4.45-430.61%
GLPGGalapagos NV4.86-461.33%
SRPTSarepta Therapeutics Inc4.88-463.06%
ABEOAbeona Therapeutics Inc5.39-500.65%
ABUSArbutus Biopharma Corp5.60-516.12%
ZVRAZevra Therapeutics Inc5.89-537.81%
SPROSpero Therapeutics Inc6.23-563.18%
CGENCompugen Ltd6.31-569.54%
RIGLRigel Pharmaceuticals6.87-611.05%
SLXNSilexion Therapeutics Corp7.30-642.58%
OMEROmeros Corporation9.26-788.53%
AUPHAurinia Pharmaceuticals Inc9.58-812.79%
PLXProtalix BioTherapeutics Inc10.89-909.92%
ACADAcadia Pharmaceuticals Inc11.73-972.20%
TBPHTheravance Biopharma Inc12.26-1011.89%
ADMAAdma Biologics Inc12.42-1023.49%
HRMYHarmony Biosciences Holdings Inc13.82-1127.75%
SABSSAB Biotherapeutics Inc14.14-1151.25%
NAGENiagen Bioscience Inc14.82-1201.96%
INCYIncyte Corp15.82-1276.66%
REGNRegeneron Pharmaceuticals Inc15.86-1279.20%
PBYIPuma Biotechnology Inc17.32-1387.70%
CPRXCatalyst Pharmaceuticals Inc17.44-1396.89%
EXELExelixis Inc17.54-1404.23%
TGTXTG Therapeutics Inc18.97-1510.43%
MDXGMimedx Group Inc20.55-1628.41%
XOMAXOMA Royalty Corp22.87-1801.14%
ARGXArgen X SE24.30-1906.99%
CTMXCytomX Therapeutics Inc24.82-1945.90%
XOMAOXOMA Royalty Corp25.34-1984.84%
HALOHalozyme Therapeutics Inc25.62-2005.58%
XOMAPXOMA Royalty Corp25.67-2009.03%
VRTXVertex Pharmaceuticals Inc27.99-2181.91%
RPRXRoyalty Pharma plc - Class A28.69-2233.43%
SLNOSoleno Therapeutics Inc29.02-2257.81%
ASNDAscendis Pharma A/S30.09-2337.40%
LGNDLigand Pharmaceuticals Inc - Class B37.91-2919.44%
APLSApellis Pharmaceuticals Inc39.02-3001.93%
BMRNBiomarin Pharmaceutical Inc42.21-3239.21%
KRYSKrystal Biotech Inc45.34-3472.10%
ONCBeiGene Ltd69.54-5271.59%
PHARPharming Group N.V.75.03-5679.50%
TECHBio-Techne Corp101.96-7682.44%
VCELVericel Corp109.92-8274.63%
ALNYAlnylam Pharmaceuticals Inc117.96-8872.83%
GMABGenmab140.29-10533.15%
TLXTelix Pharmaceuticals Ltd162.15-12158.99%
CORTCorcept Therapeutics Inc212.86-15929.80%